Laddar...
Tumor necrosis factor inhibitors in psoriatic arthritis
INTRODUCTION: Psoriatic arthritis (PsA) is a chronic inflammatory disease that can result in significant disability. With the emergence of tumor necrosis factor inhibitors (TNFi), therapeutic outcomes in PsA have improved substantially. The clinical efficacy and the inhibition of radiographic progre...
Sparad:
| I publikationen: | Expert Rev Clin Pharmacol |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6348387/ https://ncbi.nlm.nih.gov/pubmed/28490202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17512433.2017.1329009 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|